Latest Distribution Channels News

Wisr has reported a strong Q2FY26 performance, showcasing robust loan book growth and improved credit quality, while signalling a clear path to profitability in the second half of FY26.

Control Bionics has raised $3.8 million to fuel growth, forged a key distribution deal with Tobii, and integrated with Apple’s BCI protocol, while advancing its NeuroStrip and NeuroBounce platforms.

RooLife Group Ltd has reported a remarkable doubling of its coffee and food sales in China, surpassing A$2.1 million in December 2025 and signaling strong momentum in its data-driven e-commerce strategy.

Algorae Pharmaceuticals has locked in a $3 million revolving debt facility with ScotPac, providing flexible, non-dilutive funding to accelerate its commercial operations across Australia and New Zealand.

Wellnex Life reports a $2.4 million EBITDA improvement in H1 FY26 and reaches breakeven by Q2, supported by strong Pain Away sales and expanded distribution.

ECS Botanics reports a $218k positive operating cash flow in Q2 FY26, driven by strong B2C growth and new product launches. The company also secured $1.95 million in funding to fuel European expansion and product development.

Sparc Technologies has achieved a significant commercial milestone with its first sale of ecosparc®, a graphene-based additive for protective coatings, to an Asian coatings company following successful proof-of-concept testing.

HITIQ Limited and Sportscover have forged an exclusive partnership to embed PROTEQT™, a cutting-edge concussion management system, into Sportscover’s sports insurance policies, starting with Hockey Australia and set to expand further.

SportsHero Limited’s new HeroPlay mobile gaming platform is off to a strong start in Indonesia, attracting nearly 300 daily subscribers and generating early revenue that validates its market strategy.

Skin Elements Limited has completed a $2.5 million placement to fund the commercial rollout of its ECO Nurture bio-stimulant, targeting sustainable kiwifruit orchard protection in New Zealand.

Steadfast Group reveals robust acquisition activity and strategic cost optimizations in its latest investor update, signaling strong momentum across its Australasian and international operations.

Memphasys Limited has restructured its leadership by eliminating the CEO role to back a direct-selling global commercialisation strategy for its Felix™ System, anticipating imminent CE Mark approval to enter the European IVF market.